Journal profile · Immunology and Microbiology-Immunology
International Journal of Immunopathology and Pharmacology
ISSN 2058-7384 · SAGE Publications Inc. · Italy
International Journal of Immunopathology and Pharmacology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.76; fully open access; APC about USD 2,650; review about 15 weeks (community reports); acceptance rate 6.3% (journal website); 56 articles in 2025; indexed in SCIE and Scopus; flagged on an early-warning list or for an indexing change: check before submitting.
Scope
Aims, scope and focus
International Journal of Immunopathology and Pharmacology is published by SAGE Publications Inc. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Allergic Rhinitis and Sensitization and Immune Cell Function and Interaction, together about 25.4% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
International Journal of Immunopathology and Pharmacology is a peer-reviewed open access journal that publishes original papers describing research in the fields of immunology, pathology and pharmacology. Please see the Aims and Scope tab for further information.This journal is a member of the Committee on Publication Ethics (COPE). Indexed in: PubMed, SCIE & ScopusPublished by SAGE since 2016An expert and prestigious Editorial BoardPublication is subject to payment of an article processing charge (APC). Submission informationSubmit your manuscript today at https://mc.manuscriptcentral.com/iji Please see the Submission Guidelines tab for more information on how to submit your article to the journal. Open access article processing charge (APC) informationThe article processing charge (APC) is $3200.The article processing charge (APC) is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.ContactPlease direct any queries to shiva.sanivada@sagepub.in*The article processing charge (APC) is payable when the manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Tax-exempt status can be indicated by providing appropriate registration numbers when payment is requested. Please see further details here.
From the journal's Aims & Scope
Research area (LetPub): Immunology and Microbiology-Immunology
Editorial board by country: none in mainland China; most named United States 13, Italy 8, India 3, United Kingdom 2, France 2 (41 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine9.9%
- Allergic Rhinitis and SensitizationMedicine8.9%
- Immune Cell Function and InteractionImmunology and Microbiology6.6%
- Dermatology and Skin DiseasesMedicine5.4%
- Food Allergy and Anaphylaxis ResearchMedicine5.3%
- T-cell and B-cell ImmunologyImmunology and Microbiology4.8%
- Immunotherapy and Immune ResponsesImmunology and Microbiology4.5%
- Contact Dermatitis and AllergiesMedicine4.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Pathology | Zone 3 |
| Minor | Immunology | Zone 4 |
| Minor | Pharmacology & Pharmacy | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Immunology | Zone 3 |
| Minor | Pathology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pathology | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
| Minor | Immunology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusDOAJLetPub
Early warning / risk: CAS Early Warning Journal List: listed in the 2020 edition (medium risk); not listed in the other 5 editions.LetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.76LetPub ·
- Impact factor (publisher)
- 2.8Publisher website ·
- 5-year impact factor (publisher)
- 3Publisher website ·
- CiteScore 2026-06
- 5.1LetPub ·
- SJR 2026-06
- 0.72LetPub ·
- SNIP 2026-06
- 0.65LetPub ·
- h-index
- 77OpenAlex ·
- i10-index
- 1,504OpenAlex ·
- 2-year mean citedness
- 3.51OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 99.02%LetPub ·
Volume
- Articles per year
- 53LetPub ·
- Articles per year (publisher)
- 3Publisher website ·
Articles by year OpenAlex count · 2,629 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 22 | 22 | 8 |
| 2025 | 56 | 56 | 157 |
| 2024 | 77 | 77 | 379 |
| 2023 | 78 | 78 | 758 |
| 2022 | 90 | 90 | 1,032 |
| 2021 | 115 | 115 | 1,932 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- about 15 weeksLetPub ·
- Acceptance rate (publisher)
- 6.3%Publisher website ·
- Submission to first decision
- 3 daysPublisher website ·
- Acceptance to publication
- 36 daysPublisher website ·
- Submission to publication (journal-reported)
- about 15 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 2,650 | Yes | CC BY, CC BY-NC | |
| OpenAlex | USD 2,650 | — | — | |
| LetPub | USD 2,650 | Yes | — | |
| Publisher website | USD 3,200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare8 items from the author guidelines
- Abstract
- ≤ 250 words
- Manuscript length
- ≤ 1,500 words
- Reference style
- Vancouver
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Required
- Highlights
- Required
- Graphical abstract
- Required
- Cover letter
- Required
Article types accepted11, with length limits
- case reportView our Special Collections currently accepting submissions. The journal publishes original papers describing research in the fields of immunology, pathology, …main text ≤ 1,000 words
- case reportsCase reports: A case report may include a single case study or case series. They should be based on an interesting observation, or an unique case. Case reports …Length not stated
- correspondenceView our Special Collections currently accepting submissions. The journal publishes original papers describing research in the fields of immunology, pathology, …Length not stated
- editorialView our Special Collections currently accepting submissions. The journal publishes original papers describing research in the fields of immunology, pathology, …Length not stated
- letters to the editorView our Special Collections currently accepting submissions. The journal publishes original papers describing research in the fields of immunology, pathology, …Length not stated
- literature reviewView our Special Collections currently accepting submissions. The journal publishes original papers describing research in the fields of immunology, pathology, …Length not stated
- original paperView our Special Collections currently accepting submissions. The journal publishes original papers describing research in the fields of immunology, pathology, …Length not stated
- original researchView our Special Collections currently accepting submissions. The journal publishes original papers describing research in the fields of immunology, pathology, …Length not stated
- reviewView our Special Collections currently accepting submissions. The journal publishes original papers describing research in the fields of immunology, pathology, …main text ≤ 5,000 words
- reviewsReviews: literature reviews, systematic reviews, market reviews and critical reviews will be accepted for consideration. Reviews must contain no more than 5,000…Length not stated
- systematic reviewView our Special Collections currently accepting submissions. The journal publishes original papers describing research in the fields of immunology, pathology, …Length not stated
Policy excerpts from the journal's websiteAuthorship, Data availability, Publication ethics, Open access, Peer review, Plagiarism, Preprints, Trial registration / reporting guidelines
- Authorship Author contributions
You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.
Source ↗Publisher website ·- Data availability Data availability
The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. As a condition of publication authors are required to: Share your research data in a relevant public data repository Include a data availability statement. This sho…
Source ↗Publisher website ·- Publication ethics Ethical considerations
Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…
Source ↗Publisher website ·- Open access Publishing fees and open access
International Journal of Immunopathology and Pharmacology is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the…
Source ↗Publisher website ·- Peer review Peer review policy
Single anonymized review Model summary
The following summary describes the peer review process for this journal: Identity transparency: Single-anonymized Reviewer interacts with: Editor Review information published: None Your manuscript will undergo an initial evaluation. If it does not conform to the requirements laid out in these guidelines, it will be returned to you for amendments prior to peer review. Manuscripts may be desk rejec…
Source ↗Publisher website ·- Plagiarism Plagiarism
The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.
Source ↗Publisher website ·- Preprints Preprints
The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical trial registration
The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- SAGE Publications Inc.
- Country or region
- Italy
- Language
- English
- ISSN
- 2058-7384
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Aims & Scope ↗LetPub
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗LetPub
- Editorial board ↗LetPub
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about International Journal of Immunopathology and Pharmacology
What CAS zone is International Journal of Immunopathology and Pharmacology in?
In the 2025 upgraded edition of the CAS Journal Ranking, International Journal of Immunopathology and Pharmacology is in Zone 4 of Medicine, and in Zone 3 of the minor category Pathology / Immunology / Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of International Journal of Immunopathology and Pharmacology?
The latest impact factor listed by LetPub is 2.76; CiteScore 5.1, h-index 77.
How long does peer review take at International Journal of Immunopathology and Pharmacology?
Authors report an average review time of about 15 weeks; the journal's website gives an acceptance rate of 6.3%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of International Journal of Immunopathology and Pharmacology?
According to the journal's author guidelines: Abstract: ≤ 250 words; Manuscript length: ≤ 1,500 words; Reference style: Vancouver; First submission: Free format: the journal's layout is not required; Suggested reviewers: Required; Highlights: Required; Graphical abstract: Required; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of International Journal of Immunopathology and Pharmacology based?
Of the 41 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (13), Italy (8) and India (3). Counted from the institutions listed on the board page; for reference only.
Which databases index International Journal of Immunopathology and Pharmacology?
According to LetPub and DOAJ records, International Journal of Immunopathology and Pharmacology is indexed in SCIE, Scopus and DOAJ.
Is International Journal of Immunopathology and Pharmacology open access, and what is the APC?
International Journal of Immunopathology and Pharmacology is a fully open-access journal. APC about USD 2,650.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .